
Patricia Ann Duffy
Examiner (ID: 7333)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1806, 1648, 1802, 1645, 1818 |
| Total Applications | 1671 |
| Issued Applications | 766 |
| Pending Applications | 244 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4493628
[patent_doc_number] => 07947268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-24
[patent_title] => 'Salmonella based oral vaccines for anthrax'
[patent_app_type] => utility
[patent_app_number] => 12/084998
[patent_app_country] => US
[patent_app_date] => 2006-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 34
[patent_no_of_words] => 11876
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/947/07947268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12084998
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/084998 | Salmonella based oral vaccines for anthrax | Nov 13, 2006 | Issued |
Array
(
[id] => 5028367
[patent_doc_number] => 20070269814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'METHOD OF PATHOGEN OR CHEMICAL DETECTION'
[patent_app_type] => utility
[patent_app_number] => 11/558586
[patent_app_country] => US
[patent_app_date] => 2006-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10481
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269814.pdf
[firstpage_image] =>[orig_patent_app_number] => 11558586
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/558586 | METHOD OF PATHOGEN OR CHEMICAL DETECTION | Nov 9, 2006 | Abandoned |
Array
(
[id] => 5016237
[patent_doc_number] => 20070259446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'Assay reagents and devices'
[patent_app_type] => utility
[patent_app_number] => 11/595820
[patent_app_country] => US
[patent_app_date] => 2006-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2116
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259446.pdf
[firstpage_image] =>[orig_patent_app_number] => 11595820
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/595820 | Assay reagents and devices | Nov 8, 2006 | Abandoned |
Array
(
[id] => 4866320
[patent_doc_number] => 20080145379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections'
[patent_app_type] => utility
[patent_app_number] => 11/591569
[patent_app_country] => US
[patent_app_date] => 2006-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 17476
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145379.pdf
[firstpage_image] =>[orig_patent_app_number] => 11591569
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/591569 | Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections | Nov 1, 2006 | Abandoned |
Array
(
[id] => 5337276
[patent_doc_number] => 20090053740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'AGGLUTINATION-BASED METHOD FOR FAST DETECTION, ISOLATION AND QUANTIFICATION OF APOPTOTIC CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/088973
[patent_app_country] => US
[patent_app_date] => 2006-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15307
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20090053740.pdf
[firstpage_image] =>[orig_patent_app_number] => 12088973
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/088973 | AGGLUTINATION-BASED METHOD FOR FAST DETECTION, ISOLATION AND QUANTIFICATION OF APOPTOTIC CELLS | Oct 30, 2006 | Abandoned |
Array
(
[id] => 7692689
[patent_doc_number] => 20070231344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Conjugate vaccines for non-proteinaceous antigens'
[patent_app_type] => utility
[patent_app_number] => 11/589686
[patent_app_country] => US
[patent_app_date] => 2006-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17112
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231344.pdf
[firstpage_image] =>[orig_patent_app_number] => 11589686
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/589686 | Conjugate vaccines for non-proteinaceous antigens | Oct 29, 2006 | Abandoned |
Array
(
[id] => 5490391
[patent_doc_number] => 20090291462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'Detection or Quantification of Aggrecan and its Fragments'
[patent_app_type] => utility
[patent_app_number] => 12/083900
[patent_app_country] => US
[patent_app_date] => 2006-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5227
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291462.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083900
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083900 | Detection or Quantification of Aggrecan and its Fragments | Oct 16, 2006 | Abandoned |
Array
(
[id] => 5079648
[patent_doc_number] => 20070122872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Method for storage of clinical samples prior to culture'
[patent_app_type] => utility
[patent_app_number] => 11/581550
[patent_app_country] => US
[patent_app_date] => 2006-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5691
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122872.pdf
[firstpage_image] =>[orig_patent_app_number] => 11581550
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/581550 | Method for storage of clinical samples prior to culture | Oct 15, 2006 | Abandoned |
Array
(
[id] => 6352469
[patent_doc_number] => 20100249372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'Botulinum neurotoxin a receptor and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/546880
[patent_app_country] => US
[patent_app_date] => 2006-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13390
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249372.pdf
[firstpage_image] =>[orig_patent_app_number] => 11546880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/546880 | Botulinum neurotoxin A receptor and the use thereof | Oct 11, 2006 | Issued |
Array
(
[id] => 5193517
[patent_doc_number] => 20070082001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Novel engineered superantigen for human therapy'
[patent_app_type] => utility
[patent_app_number] => 11/526437
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17974
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082001.pdf
[firstpage_image] =>[orig_patent_app_number] => 11526437
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/526437 | Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigen | Sep 24, 2006 | Issued |
Array
(
[id] => 5539250
[patent_doc_number] => 20090221055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'Novel Bacillus Subtilis Mutant Strain'
[patent_app_type] => utility
[patent_app_number] => 12/083539
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17212
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221055.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083539
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083539 | Bacillus subtilis mutant strain | Sep 24, 2006 | Issued |
Array
(
[id] => 5096140
[patent_doc_number] => 20070117749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Production of mersacidin and its variants in SigH and/or mrsA negative bacillus host cells'
[patent_app_type] => utility
[patent_app_number] => 11/526225
[patent_app_country] => US
[patent_app_date] => 2006-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25374
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20070117749.pdf
[firstpage_image] =>[orig_patent_app_number] => 11526225
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/526225 | F3W variants of the lantibiotic mersacidin and its use | Sep 24, 2006 | Issued |
Array
(
[id] => 5171343
[patent_doc_number] => 20070071774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-29
[patent_title] => 'Protein D - an IgD-binding protein of Haemophilus influenzae'
[patent_app_type] => utility
[patent_app_number] => 11/521598
[patent_app_country] => US
[patent_app_date] => 2006-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7167
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20070071774.pdf
[firstpage_image] =>[orig_patent_app_number] => 11521598
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/521598 | Methods of producing recombinant protein D | Sep 14, 2006 | Issued |
Array
(
[id] => 4971234
[patent_doc_number] => 20070111236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Streptococcus suis vaccines and diagnostic tests'
[patent_app_type] => utility
[patent_app_number] => 11/516691
[patent_app_country] => US
[patent_app_date] => 2006-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 22623
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111236.pdf
[firstpage_image] =>[orig_patent_app_number] => 11516691
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/516691 | Streptococcus suis vaccines and diagnostic tests | Sep 4, 2006 | Issued |
Array
(
[id] => 4455325
[patent_doc_number] => 07892569
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Methods of altering an immune response induced by CpG oligodeoxynucleotides'
[patent_app_type] => utility
[patent_app_number] => 12/065085
[patent_app_country] => US
[patent_app_date] => 2006-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 16647
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/892/07892569.pdf
[firstpage_image] =>[orig_patent_app_number] => 12065085
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/065085 | Methods of altering an immune response induced by CpG oligodeoxynucleotides | Aug 27, 2006 | Issued |
Array
(
[id] => 4483000
[patent_doc_number] => 07901907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-08
[patent_title] => 'Process for production of Helicobacter pylori bacterioferritin'
[patent_app_type] => utility
[patent_app_number] => 11/510509
[patent_app_country] => US
[patent_app_date] => 2006-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4146
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/901/07901907.pdf
[firstpage_image] =>[orig_patent_app_number] => 11510509
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/510509 | Process for production of Helicobacter pylori bacterioferritin | Aug 24, 2006 | Issued |
Array
(
[id] => 10837983
[patent_doc_number] => 08865657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-21
[patent_title] => 'Compositions and methods for inactivating or suppressing inflammatory cells'
[patent_app_type] => utility
[patent_app_number] => 11/506611
[patent_app_country] => US
[patent_app_date] => 2006-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 46755
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11506611
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/506611 | Compositions and methods for inactivating or suppressing inflammatory cells | Aug 17, 2006 | Issued |
Array
(
[id] => 6607527
[patent_doc_number] => 20100099120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Method for staining substances having a phosphate group'
[patent_app_type] => utility
[patent_app_number] => 11/989817
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6971
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099120.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989817
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989817 | Method for staining substances having a phosphate group | Aug 8, 2006 | Abandoned |
Array
(
[id] => 5130759
[patent_doc_number] => 20070207156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules'
[patent_app_type] => utility
[patent_app_number] => 11/501999
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9722
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207156.pdf
[firstpage_image] =>[orig_patent_app_number] => 11501999
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/501999 | Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules | Aug 8, 2006 | Issued |
Array
(
[id] => 8269941
[patent_doc_number] => 08211442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Mucosal vaccine enabling switching from production of IgA antibody to production of both of IgA and IgG antibodies'
[patent_app_type] => utility
[patent_app_number] => 11/990001
[patent_app_country] => US
[patent_app_date] => 2006-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 14955
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11990001
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990001 | Mucosal vaccine enabling switching from production of IgA antibody to production of both of IgA and IgG antibodies | Aug 3, 2006 | Issued |